Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Trial ID or NCT#



not recruiting iconNOT RECRUITING


This clinical trial is studying the side effects of combination chemotherapy and to see how well they work in treating patients with newly diagnosed localized Ewing sarcoma family of tumors. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving the drugs in different ways may kill more tumor cells.

Official Title

A Pilot Study of Chemotherapy Intensification by Adding Vincristine, Topotecan and Cyclophosphamide to Standard Chemotherapy Agents With an Interval Compression Schedule in Newly Diagnosed Patients With Localized Ewing Sarcoma Family of Tumors

Eligibility Criteria

Ages Eligible for Study: Younger than 30 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Sheri Spunt
Neyssa Marina

Contact us to find out if this trial is right for you.


Peds Hem/Onc CRAs